Conformis Inc. [NASDAQ: CFMS] closed the trading session at $1.35 on 07/23/21. The day’s price range saw the stock hit a low of $1.29, while the highest price level was $1.51. The company report on July 15, 2021 that Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference.
Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at the Canaccord Genuity 40th Annual Growth Conference.
The virtual presentation is scheduled for Wednesday, August 11, 2021 at 4:00 p.m. ET. A live webcast of the presentation will be available at https://wsw.com/webcast/canaccord60/cfms/2438788.
The stocks have a year to date performance of 104.55 percent and weekly performance of 19.47 percent. The stock has been moved at -3.57 percent over the last six months. The stock has performed 14.41 percent around the most recent 30 days and changed 43.14 percent over the most recent 3-months.
If compared to the average trading volume of 2.87M shares, CFMS reached to a volume of 9944706 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Conformis Inc. [CFMS]:
BTIG Research have made an estimate for Conformis Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 01, 2019. The new note on the price target was released on January 02, 2018, representing the official price target for Conformis Inc. stock. On August 04, 2017, analysts decreased their price target for CFMS shares from 6 to 5.
The Average True Range (ATR) for Conformis Inc. is set at 0.10, with the Price to Sales ratio for CFMS stock in the period of the last 12 months amounting to 3.75. The Price to Book ratio for the last quarter was 2.01, with the Price to Cash per share for the same quarter was set at 0.57.
CFMS stock trade performance evaluation
Conformis Inc. [CFMS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.47. With this latest performance, CFMS shares gained by 14.41% in over the last four-week period, additionally sinking by -3.57% over the last 6 months – not to mention a rise of 72.63% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CFMS stock in for the last two-week period is set at 72.71, with the RSI for the last a single of trading hit 79.11, and the three-weeks RSI is set at 68.43 for Conformis Inc. [CFMS]. The present Moving Average for the last 50 days of trading for this stock 1.04, while it was recorded at 1.27 for the last single week of trading, and 0.92 for the last 200 days.
Conformis Inc. [CFMS]: An insightful look at the core fundamentals
Conformis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.90 and a Current Ratio set at 4.30.
Earnings per share (EPS) analysis for Conformis Inc. [CFMS] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CFMS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Conformis Inc. go to -14.58%.
Conformis Inc. [CFMS]: Insider Ownership positions
There are presently around $102 million, or 50.70% of CFMS stock, in the hands of institutional investors. The top three institutional holders of CFMS stocks are: WASATCH ADVISORS INC with ownership of 17,719,186, which is approximately New of the company’s market cap and around 2.80% of the total institutional ownership; CONSONANCE CAPITAL MANAGEMENT LP, holding 13,000,000 shares of the stock with an approximate value of $17.55 million in CFMS stocks shares; and VANGUARD GROUP INC, currently with $10.0 million in CFMS stock with ownership of nearly 133.742% of the company’s market capitalization.
Positions in Conformis Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 50 institutional holders increased their position in Conformis Inc. [NASDAQ:CFMS] by around 58,151,522 shares. Additionally, 10 investors decreased positions by around 1,521,117 shares, while 26 investors held positions by with 16,022,850 shares. The mentioned changes placed institutional holdings at 75,695,489 shares, according to the latest SEC report filing. CFMS stock had 32 new institutional investments in for a total of 50,120,801 shares, while 6 institutional investors sold positions of 908,268 shares during the same period.